To the content
4 . 2020

Deprescribing of anti-diabetic medicines in the elderly and senile age people with type 2 diabetes mellitus

Abstract

The aim of this study is evaluate the safety and efficacy to stop or switch to another antidiabetic drugs in elderly and senile people with type 2 diabetes. As a result of the study, against the background of the correction of glucose-lowering therapy, all patients noted during inpatient treatment a decrease in episodes of hypoglycemia, in glycemic variability, and an improvement in well-being.

Keywords: diabetes mellitus, antidiabetic drugs, hypoglycemia, deprescribing, elderly, geriatric

Funding. The study had no sponsor support.

Conflict of interests. The authors declare no conflict of interests.

For citation: Lazareva R.V., Demidova T.Yu. Deprescribing of anti-diabetic medicines in the elderly and senile age people with type2 diabetes mellitus. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (4): 95–6. DOI: https://doi.org/10.33029/2304-9529-2020-9-4-95-96 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»